Research centers and facilities
The genomic era has completely revolutionized the medical approach to disease, paving the way for personalized treatments. Human Technopole’s mission is to contribute to the development of Personalized Medicine in the treatment of cancer and neurodegenerative diseases. To this end, HT will lead a cross-disciplinary research project, spanning among different disciplines: fundamental and clinical genomics, nutrition, innovative algorithms for data analysis, multiscale methods in computational life sciences, and advanced technologies for food and diagnostics.
To achieve its ambitious purpose, a groundbreaking infrastructure comprising 7 research centers and 4 facilities will be created, granting multi and inter-disciplinary approaches, collaboration and inclusion, creativity and ethics, empowering innovation and knowledge exchange.
The research centers will have their primary infrastructure at the Arexpo site, but may also have collaborations outside, according to specific inter-institutional agreements. Each center may comprise one or more laboratories and will pursue several well-defined research lines. Three main scientific facilities will support the activity of the research centers; a fourth facility (F4) will group laboratories and services of common interest.
will contribute to the implementation of Precision Medicine by applying genomics in oncology in order to develop new diagnostic tools and innovative therapies. It will create a National Center in Onco Genomics to improve medical genomics’ benefits to all cancer patients
will establish and apply Precision Medicine to neurodegenerative diseases, focusing on Alzheimer’s disease, Parkinson’s disease, Amyotrophic Lateral Sclerosis and related disorders because of their staggering social impact
will explore diet-health homeostasis, design bioactive personalized foods derived from self-sustainable agriculture systems, and ensure safer, healthier, and more sustainable food production
will develop a scientific framework to efficiently extract information from large sets of heterogeneous data with the aim of generating structured knowledge
will integrate computational and bioinformatics activities to study disease-associated biological processes in order to discover innovative and personalized therapies for cancer and neurodegenerative diseases
will develop original research at the intersection of computer science, mathematics, statistics, artificial intelligence, and socioeconomic sciences, endowing the Human Technopole with advanced data-handling tools and solutions
will develop material science and nanotechnologies for applications in food, nutrition, health and medicine to deliver innovative technological platforms and devices
will comprise specialized technological platforms to implement the essential “omics” technologies shared between the OGC, NGC and AFNG
will comprise a cryo-electron microscopy infrastructure
will develop in collaboration with CINECA a national infrastructure for data storage and will provide solutions of HPC to manage petabytes-to-exabytes of data generated each year by precision medicine approaches
will host laboratories and services of common interest to all research centers